Page 50 - Read Online

Kulkarni et al. J Cancer Metastasis Treat 2021;7:31 https://dx.doi.org/10.20517/2394-4722.2021.36 Page 7 of 8

DECLARATIONS
Authors’ contributions
Concept proposal: Kulkarni AA, Wilson G, Fujioka N, Patel MR
Extracting data and literature review: Kulkarni AA, Wilson G, Fujioka N, Patel MR
Manuscript writing and editing: Kulkarni AA, Wilson G, Fujioka N, Patel MR

Availability of data and materials
Not applicable.

Financial support and sponsorship
Kulkarni AA - University of Minnesota COVID-19 Rapid Response grant.

Conflicts of interest
The authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. DOI PubMed
2. CDC COVID data tracker. Available from: https://covid.cdc.gov/covid-data-tracker/#county-view [Last accessed on 26 May 2021].
DOI PubMed PMC
3. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature
2020;584:430-6. DOI PubMed
4. Docherty AB, Harrison EM, Green CA, et al; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using
the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985. DOI PubMed
PMC
5. Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ
Evid Based Med 2021;26:107-8. DOI PubMed PMC
6. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150
patients from Wuhan, China. Intensive Care Med 2020;46:846-8. DOI PubMed PMC
7. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet
2020;395:1907-18. DOI PubMed PMC
8. Lee LY, Cazier J, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a
prospective cohort study. Lancet 2020;395:1919-26. DOI PubMed PMC
9. Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19
outbreak. Cancer Discov 2020;10:783-91. DOI PubMed PMC
10. Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer
Discov 2020;10:935-41. DOI PubMed PMC
11. Garassino MC, Whisenant JG, Huang L, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an
international, registry-based, cohort study. Lancet Oncol 2020;21:914-22. DOI PubMed PMC
12. Guan WJ, Ni ZY, Hu Y, et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease
2019 in China. N Engl J Med 2020;382:1708-20. DOI PubMed PMC
13. Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-
19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21:904-13. DOI PubMed PMC
14. Yarza R, Bover M, Paredes D, et al. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features
and predictive factors for severe respiratory failure and death. Eur J Cancer 2020;135:242-50. DOI PubMed PMC
15. Assaad S, Avrillon V, Fournier ML, et al. High mortality rate in cancer patients with symptoms of COVID-19 with or without
detectable SARS-COV-2 on RT-PCR. Eur J Cancer 2020;135:251-9. DOI PubMed PMC